Clinical Trial Update: Comparison of BioCart™II With Microfracture for Treatment of Cartilage Defects of the Femoral Condyle [Phase 2]

View source ↗

Summary

Phase 2 clinical trial comparing BioCart II with Microfracture for symptomatic osteochondral defects of the femoral condyle.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Osteochondral Defect of the Femoral Condyle

Drugs mentioned

• BioCart II

Snippet

Sponsor: ProChon Biotech Ltd | Conditions: Symptomatic Cartilage Defects of the Femoral Condyle | Phase 2 | Status: UNKNOWN